Obstetrics & Gynecology · Ogden, UT
NPI
1972714954
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4403 Harrison Blvd, Suite 4440
Ogden, UT, 84403
Phone (801) 387-3740
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$224K
1,269 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Minita Patel prescribed most often to Medicare patients was Estradiol, with 255 prescriptions and refills. In total Minita Patel wrote 1,269 Medicare prescriptions that cost $224K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 255 | 1,138 | 172 | $12K |
| Methenamine Hippurate Generic | 116 | 355 | 58 | $11K |
| Cefadroxil Generic | 95 | 95 | 75 | $1,080 |
| Trospium Chloride Generic | 82 | 256 | 40 | $4,038 |
| Myrbetriq Mirabegron | 80 | 196 | 40 | $110K |
| Yuvafem Estradiol | 64 | 134 | 30 | $6,912 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 60 | 60 | 51 | $628 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 51 | 41 | $286 |
| Ciprofloxacin Hcl Generic | 45 | 45 | 39 | $271 |
| Estring Estradiol | 41 | 122 | 19 | $25K |
| Meloxicam Generic | 38 | 40 | 36 | $219 |
| Vandazole Metronidazole | 36 | 44 | 24 | $1,803 |
| Fosfomycin Tromethamine Generic | 35 | 37 | 27 | $2,779 |
| Lidocaine Generic | 34 | 38 | 24 | $610 |
| Mirabegron Er Mirabegron | 32 | 81 | 27 | $24K |
Brand drugs: 162 claims; generic drugs: 1,107 claims; opioid claims: 34.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Minita Patel were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.